Caleb Banta-Green, PhD, MPH, MSW

Dr. Banta-Green studies substance use involving opioids and stimulants and interventions to support recovery and reduce substance-related harms. He is particularly interested in developing interventions that are accessible to all people, including those who are most marginalized, such as those who are unhoused, utilizing services syringe service programs, and/or in the criminal legal system. He provides technical assistance and evaluation services for public health and safety interventions including the website http://stopoverdose.org, and information for the general public and professionals about effective treatments at http://learnabouttreatment.org. As an epidemiologist he develops innovative approaches to measuring the use and impacts of substances as well as service utilization. His health services research involves clinical trials, implementation research, and secondary data analyses. He serves on local, state, and federal workgroups and committees related to epidemiology, policy, and interventions for illicit substance-related problems. He is a member of the U.S. Health and Human Service’s Interdepartmental Substance Use Disorders Coordinating Committee.

Department Affiliations

Other Affiliations

School of Public Health, Department of Health Services

Harborview Injury Prevention & Research Center

Recent Publications

Beyond Fentanyl Test Strips: Investigating Other Urine Drug Test Strips for Drug Checking Applications.
(2024 Sep)
Forensic Chem 40():
Sisco E, Appley MG, Pyfrom EM, Banta-Green CJ, Shover CL, Molina CA, Biamont B, Robinson EL

Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes.
(2024)
Subst Abuse Rehabil 15(): 173-183
Banta-Green CJ, Owens MD, Williams JR, Floyd AS, Williams-Gilbert W, Kingston S

Expanding Access to Medications for Opioid Use Disorder: Federal Policy Is Only a Part of the Solution.
(2024 Jul)
Am J Public Health 114(7): 693-695
Heidari O, Banta-Green CJ

Acceptability and anticipated effectiveness of a safe supply of opioids, among people who inject opioids in King County, WA.
(2024 May)
Int J Drug Policy 127(): 104389
Palayew A, Banta-Green CJ, Lamont M, Damper D, Moreno C, Goodreau SM, Mooney SJ, Glick SN

Emergency Room Utilization and Methamphetamine Overdose Symptoms Among Syringe Services Program Participants in Washington State.
(2024)
Subst Use Misuse 59(7): 1012-1019
Frank ND, Banta-Green CJ, Guthrie BL, Kingston S, Tinsley J, Whiteside L, Glick SN

Show complete publication list »
Edit Profile